Chronic kidney disease mineral bone disorder and health-related quality of life among incident end-stage renal-disease patients

被引:19
|
作者
Johansen, Kirsten L.
Chertow, Glenn M.
机构
[1] San Francisco VA Med Ctr, Nephrol Sect, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA USA
关键词
D O I
10.1053/j.jrn.2007.06.005
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: Our objective was to determine the extent to which chronic kidney disease mineral bone disorder (CKD-MBD) is associated with health-related quality of life among incident dialysis patients. Design: This study's design was a cross-sectional analysis. Setting: This was part of the United States Renal Data System Dialysis Morbidity and Mortality Study (DMMS), Wave 2. Patients: The patients comprised 2590 adult participants in DMMS Wave 2, for whom quality of life and laboratory data were available. Methods: We stratified patients according to their serum concentrations of phosphorus, calcium, and parathyroid hormone (PTH), and compared health-related quality of life as a function of these indicators in analyses adjusted for demographic, clinical, and other laboratory variables. Main Outcome Measures: Main outcome measures included Physical Component Summary (PCS) and Mental Component Summary (MCS) scores, and the Symptom score of the Kidney Disease Quality of Life. Results: Both high and low serum phosphorus concentrations were associated with lower PCS scores (-1.25 to -1.48 points compared with the reference category), as was low PTH (-1.49 points). Low serum phosphorus was associated with more severe symptoms of kidney disease (-3.88 points), but there were no associations between high phosphorus or either extreme of PTH and the Symptom score. Serum calcium concentration and the calcium x phosphorus product were unassociated with PCS or Symptom scores. There were no associations among phosphorus, calcium, or PTH and MCS. Analyses simultaneously controlling for serum phosphorus, calcium, and PTH showed similar results. Conclusion: High and low serum phosphorus and low PTH are associated with slightly poorer self-reported physical functioning. Clinical trials will be necessary to determine whether and to what extent improvement in health status may occur with the correction of selected disorders of mineral metabolism. (C) 2007 by the National Kidney Foundation, Inc.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 50 条
  • [41] Social Support and Religious Coping Strategies in Health-Related Quality of Life of End-Stage Renal Disease Patients
    Ibrahim, Norhayati
    Desa, Asmawati
    Chiew-Tong, Norella Kong
    Ismail, R.
    Zainah, A. Z.
    [J]. PERTANIKA JOURNAL OF SOCIAL SCIENCE AND HUMANITIES, 2011, 19 : 91 - 97
  • [42] Predictors of health-related quality of life perceived by end-stage renal disease patients under online hemodiafiltration
    Alexandra Moura
    José Madureira
    Pablo Alija
    João Carlos Fernandes
    José Gerardo Oliveira
    Martin Lopez
    Madalena Filgueiras
    Leonilde Amado
    Maria Sameiro-Faria
    Vasco Miranda
    Edgar Mesquita
    Alice Santos-Silva
    Elísio Costa
    [J]. Quality of Life Research, 2015, 24 : 1327 - 1335
  • [43] In-center nocturnal hemodialysis improves health-related quality of life for patients with end-stage renal disease
    Chance S. Dumaine
    Pietro Ravani
    Manvir K. Parmar
    Kelvin C. W. Leung
    Jennifer M. MacRae
    [J]. Journal of Nephrology, 2022, 35 : 245 - 253
  • [44] In-center nocturnal hemodialysis improves health-related quality of life for patients with end-stage renal disease
    Dumaine, Chance S.
    Ravani, Pietro
    Parmar, Manvir K.
    Leung, Kelvin C. W.
    MacRae, Jennifer M.
    [J]. JOURNAL OF NEPHROLOGY, 2022, 35 (01) : 245 - 253
  • [46] Waitlisting for Kidney Transplant and Social Determinants of Health Predict Health-Related Quality of Life (hrqol) in End-Stage Renal Disease (ESRD) Patients
    Swift, S. L.
    Wang, S.
    Chang, C. H.
    Pleis, J.
    Dew, M.
    Shapiro, R.
    Unruh, M.
    Kendall, K.
    Croswell, E.
    Peipert, J. D.
    Myaskovsky, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 981 - 981
  • [47] QUALITY OF LIFE AND REHABILITATION DIFFERENCES AMONG ALTERNATE END-STAGE RENAL-DISEASE THERAPIES
    SIMMONS, RG
    ABRESS, L
    [J]. TRANSPLANTATION PROCEEDINGS, 1988, 20 (01) : 379 - 380
  • [48] QUALITY ASSURANCE AND THE CARE OF PATIENTS WITH END-STAGE RENAL-DISEASE
    FINKELSTEIN, FO
    KITSEN, J
    [J]. JOURNAL OF CHRONIC DISEASES, 1979, 32 (9-10): : 605 - 608
  • [49] Health-related quality of life in patients with chronic kidney disease
    Hussien, Hani
    Apetrii, Mugurel
    Covic, Adrian
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (01) : 43 - 54
  • [50] Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study
    Jesky, Mark D.
    Dutton, Mary
    Dasgupta, Indranil
    Yadav, Punit
    Ng, Khai Ping
    Fenton, Anthony
    Kyte, Derek
    Ferro, Charles J.
    Calvert, Melanie
    Cockwell, Paul
    Stringer, Stephanie J.
    [J]. PLOS ONE, 2016, 11 (11):